UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapy

Leukemia, 2020-11, Vol.34 (11), p.2925-2933

2020

Volltextzugriff (PDF)

CD200 genotype is associated with clinical outcome of patients with multiple myeloma

Frontiers in immunology, 2024-02, Vol.15, p.1252445-1252445

2024

Volltextzugriff (PDF)

Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myeloma

Frontiers in immunology, 2023-04, Vol.14, p.1158105-1158105

2023

Volltextzugriff (PDF)

Population-based incidence of myeloid malignancies: fifteen years of epidemiological data in the province of Girona, Spain

Haematologica (Roma), 2013-08, Vol.98 (8), p.e95-e97

2013

Volltextzugriff (PDF)

5′‐nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate‐risk cytogenetics

European journal of haematology, 2022-12, Vol.109 (6), p.755-764

2022

Volltextzugriff (PDF)

Kinetics of the CTLA-4 isoforms expression after T-lymphocyte activation and role of the promoter polymorphisms on CTLA-4 gene transcription

Human immunology, 2013-09, Vol.74 (9), p.1219-1224

2013

Volltextzugriff (PDF)

Outcome and prognostic factors in patients with hematologic malignancies admitted to the intensive care unit : A single-center experience

International journal of hematology, 2007-04, Vol.85 (3), p.195-202

2007

Volltextzugriff (PDF)

LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors

Frontiers in immunology, 2023-01, Vol.14, p.1066393-1066393

2023

Volltextzugriff (PDF)

The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapy

Haematologica (Roma), 2005-05, Vol.90 (5), p.704-706

2005

Volltextzugriff (PDF)

Advanced Stage Is the Most Important Prognostic Factor for Survival in Patients with Systemic Acquired Immunodeficiency Syndrome-Related Non-Hodgkin's Lymphoma Treated with CHOP and Highly Active Antiretroviral Therapy

International journal of hematology, 2007-11, Vol.86 (4), p.337-342

2007

Volltextzugriff (PDF)

Is survival in myeloid malignancies really improving? A retrospective 15-year population-based study

Leukemia & lymphoma, 2015-04, Vol.56 (4), p.896-902

2015

Volltextzugriff (PDF)

Lymphopenia and changes on peripheral blood immunophenotype in patients with hepatobiliarypancreatic tumors treated with chemoradiotherapy

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e15610-e15610

2016

Volltextzugriff (PDF)

Visceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with adalimumab

Joint, bone, spine : revue du rhumatisme, 2010-05, Vol.77 (3), p.271-273

2010

Volltextzugriff (PDF)

Donor CTLA-4 Genotype Influences Clinical Outcome after T Cell-Depleted Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Identical Sibling Donors

Biology of blood and marrow transplantation, 2012, Vol.18 (1), p.100-105

2012

Volltextzugriff (PDF)

Clinical usefulness of fluorescence in situ hybridization for detection of MLL rearrangements in acute myeloid leukemia

Leukemia & lymphoma, 2015-09, Vol.56 (9), p.2706-2708

2015

Volltextzugriff (PDF)

Management of low-risk febrile patients with neutropenia

Enfermedades infecciosas y microbiología clínica, 2005-12, Vol.23 Suppl 5, p.30-34

2005

Volltextzugriff (PDF)

Leishmaniose viscérale et syndrome d’activation macrophagique chez un patient atteint de polyarthrite rhumatoïde traité par adalimumab

Revue du rhumatisme (Ed. française : 1993), 2010-05, Vol.77 (3), p.304-306

2010

Volltextzugriff (PDF)

Se ha sobrevalorado la razón normalizada internacional (INR)?

Medicina clínica, 2005-05, Vol.124 (18), p.718-718

2005

Volltextzugriff (PDF)

Has the international normalized ratio (INR) been overestimated?

Medicina clínica, 2005-05, Vol.124 (18), p.718-718

2005

Volltextzugriff (PDF)

Manejo del paciente con neutropenia de bajo riesgo y fiebre

Enfermedades infecciosas y microbiología clínica, 2005, Vol.23, p.30-34

2005

Volltextzugriff (PDF)

Severe Myelodysplasia with Monosomy 7 Developing during Imatinib Treatment of Philadelphia-Positive Chronic Myeloid Leukemia: Two Cases Evolving with Different Outcome

Blood, 2005-11, Vol.106 (11), p.4861-4861

2005

Volltextzugriff (PDF)

Outcome and Prognostic Factors in Patients with Hematological Malignancy That Are Admitted to the Intensive Care Unit

Blood, 2004-11, Vol.104 (11), p.5285-5285

2004

Volltextzugriff (PDF)

Interference of schistocytes in a platelet count by a Beckman Coulter counter

Laboratory hematology, 2006, Vol.12 (4), p.242

2006

Volltextzugriff (PDF)

Linfoma compuesto

Medicina clínica, 2003-09, Vol.121 (8), p.319-319

2003

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(44)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapy

CD200 genotype is associated with clinical outcome of patients with multiple myeloma

Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myeloma

Population-based incidence of myeloid malignancies: fifteen years of epidemiological data in the province of Girona, Spain

5′‐nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate‐risk cytogenetics

Kinetics of the CTLA-4 isoforms expression after T-lymphocyte activation and role of the promoter polymorphisms on CTLA-4 gene transcription

Outcome and prognostic factors in patients with hematologic malignancies admitted to the intensive care unit : A single-center experience

LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors

The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapy

Advanced Stage Is the Most Important Prognostic Factor for Survival in Patients with Systemic Acquired Immunodeficiency Syndrome-Related Non-Hodgkin's Lymphoma Treated with CHOP and Highly Active Antiretroviral Therapy

Is survival in myeloid malignancies really improving? A retrospective 15-year population-based study

Lymphopenia and changes on peripheral blood immunophenotype in patients with hepatobiliarypancreatic tumors treated with chemoradiotherapy

Visceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with adalimumab

Donor CTLA-4 Genotype Influences Clinical Outcome after T Cell-Depleted Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Identical Sibling Donors

Clinical usefulness of fluorescence in situ hybridization for detection of MLL rearrangements in acute myeloid leukemia

Prognostic Impact of the Levels of Expression of Cell Surface Proteins Commonly Expressed by Blasts and Hematopoietic Precursor Cells in De Novo AML Patients: A Report From the Spanish Cetlam Study Group

Management of low-risk febrile patients with neutropenia

Leishmaniose viscérale et syndrome d’activation macrophagique chez un patient atteint de polyarthrite rhumatoïde traité par adalimumab

Se ha sobrevalorado la razón normalizada internacional (INR)?

Has the international normalized ratio (INR) been overestimated?

Manejo del paciente con neutropenia de bajo riesgo y fiebre

Severe Myelodysplasia with Monosomy 7 Developing during Imatinib Treatment of Philadelphia-Positive Chronic Myeloid Leukemia: Two Cases Evolving with Different Outcome

Outcome and Prognostic Factors in Patients with Hematological Malignancy That Are Admitted to the Intensive Care Unit

Interference of schistocytes in a platelet count by a Beckman Coulter counter

Linfoma compuesto

Suchergebnisse filtern